Docoh
Loading...

ARWR Arrowhead Pharmaceuticals

754 filings

Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
4
ARWR Arrowhead Pharmaceuticals Inc.
14 Sep 21
ARROWHEAD PHARMACEUTICALS / ADEOYE Y OLUKOTUN ownership change
5:25pm
4
Given Douglas B
10 Sep 21
ARROWHEAD PHARMACEUTICALS / DOUGLAS B GIVEN ownership change
4:53pm
8-K
ARWR Arrowhead Pharmaceuticals Inc.
26 Aug 21
Departure of Directors or Certain Officers
8:00pm
10-Q
2021 Q3
ARWR Arrowhead Pharmaceuticals Inc.
5 Aug 21
Quarterly report
4:14pm
8-K
ARWR Arrowhead Pharmaceuticals Inc.
5 Aug 21
Arrowhead Pharmaceuticals Reports Fiscal 2021 Third Quarter Results
4:06pm
4
Backer Marianne De
25 Jun 21
ARROWHEAD PHARMACEUTICALS / Backer Marianne De ownership change
6:59pm
4
James Hassard
24 Jun 21
ARROWHEAD PHARMACEUTICALS / James Hassard ownership change
6:44pm
4
Given Douglas B
24 Jun 21
ARROWHEAD PHARMACEUTICALS / DOUGLAS B GIVEN ownership change
4:47pm
8-K
ARWR Arrowhead Pharmaceuticals Inc.
22 Jun 21
Arrowhead Pharmaceuticals and Horizon Therapeutics Announce Collaboration to Develop RNAi Therapeutic for Uncontrolled Gout
4:09pm
8-K
ARWR Arrowhead Pharmaceuticals Inc.
16 Jun 21
Other Events
4:05pm
S-8
ARWR Arrowhead Pharmaceuticals Inc.
18 May 21
Registration of securities for employees
4:11pm
10-Q
2021 Q2
ARWR Arrowhead Pharmaceuticals Inc.
4 May 21
Quarterly report
4:10pm
8-K
ARWR Arrowhead Pharmaceuticals Inc.
4 May 21
Arrowhead Pharmaceuticals Reports Fiscal 2021 Second Quarter Results
4:05pm
8-K
ARWR Arrowhead Pharmaceuticals Inc.
24 Mar 21
Departure of Directors or Certain Officers
5:15pm
UPLOAD
ARWR Arrowhead Pharmaceuticals Inc.
7 Mar 21
Letter from SEC
7:00pm
4
Given Douglas B
24 Feb 21
ARROWHEAD PHARMACEUTICALS / DOUGLAS B GIVEN ownership change
6:51pm
4
Patrick O'Brien
10 Feb 21
ARROWHEAD PHARMACEUTICALS / Patrick O'Brien ownership change
5:56pm
SC 13G/A
ARWR Arrowhead Pharmaceuticals Inc.
10 Feb 21
ARROWHEAD PHARMACEUTICALS / VANGUARD ownership change
10:30am
CORRESP
ARWR Arrowhead Pharmaceuticals Inc.
4 Feb 21
Correspondence with SEC
7:00pm
10-Q
2021 Q1
ARWR Arrowhead Pharmaceuticals Inc.
4 Feb 21
Quarterly report
4:10pm